Aubagio EU Backing Comes With Generic Worries
Seeking Alpha
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Genzyme presents second Phase III study of once-daily AUBAGIO
Yahoo/Fly on the Wall
Battle Lines Drawn in the MS Market
Motley Fool
Multiple sclerosis drugs seen gaining traction
Marketwatch
Sanofi: A Long-Term Winner On These FDA Approvals
Seeking Alpha